Filter
480
Filtered Results: 480
Text search:
in
vitro
diagnostic
tests
Featured
Recommendations
67
New Publications
100
Language
Document type
No document type
218
Guidelines
126
Studies & Reports
57
Manuals
43
Fact sheets
14
Strategic & Response Plan
13
Training Material
5
Situation Updates
2
Resource Platforms
2
Countries / Regions
India
24
Germany
15
Global
12
South Africa
11
Latin America and the Carribbean
11
Africa
10
Western and Central Europe
8
Russia
7
Ethiopia
5
Kenya
5
Tanzania
5
Rwanda
5
Nigeria
4
Cameroon
4
Namibia
4
Brazil
4
Eastern Europe
4
Burkina Faso
3
Uganda
3
Zambia
3
West and Central Africa
3
Congo-Brazzaville
3
Sierra Leone
2
Senegal
2
Congo, Democratic Republic of
2
Mali
2
Côte d’Ivoire / Ivory Coast
2
Niger
2
Haiti
2
Nepal
2
Bangladesh
2
Malawi
2
Benin
2
Argentina
2
Eswatini/ Swaziland
2
Ukraine
2
Madagascar
2
Myanmar / Burma
2
East and Southern Africa
2
Middle East and North Africa
2
Asia
2
Venezuela
2
France
2
Guinea
1
Liberia
1
USA
1
Togo
1
Zimbabwe
1
Philippines
1
South Sudan
1
Turkey
1
Syria
1
Gambia
1
Indonesia
1
Peru
1
Burundi
1
Colombia
1
Bolivia
1
Angola
1
Chile
1
Yemen
1
South–East Asia Region
1
Luxembourg
1
Albania
1
Djibouti
1
Southern Africa
1
Laos
1
Canada
1
North America
1
Belgium
1
Authors & Publishers
Publication Years
Category
Countries
109
Clinical Guidelines
107
Pharmacy & Technologies
40
Public Health
15
Women & Child Health
15
Key Resources
9
Toolboxes
TB
69
COVID-19
66
HIV
65
AMR
32
NTDs
29
Rapid Response
21
Pharmacy
16
Zika
12
Ebola
11
Refugee
10
Caregiver
8
Polio
6
Mental Health
3
Planetary Health
3
Cholera
2
Global Health Education
2
Natural Hazards
1
Specific Hazards
1
NCDs
1
These guidelines provide evidence-based guidance on the use of peripartum antiviral prophylaxis in HBsAg-positive pregnant women for the prevention of mother-to-child transmission of HBV.
Lateral-flow rapid diagnostic tests (RDTs) continue to play a vital role in global health in the...
Three classess of tests are now recommended in the latest consolidated guideles on tests for tuberculosis infection. It includes for the first-time...
July 2018
This fourth edition of the Unitaid/WHO market and technology landscape: HIV rapid diagnostic tests for self-testing report summarizes the current HIV testing gap; the challenges facing...
Information Note
Advice for countries using or planning
to introduce dual HIV/syphilis RDT in antenatal services and other testing sites.
WHO/RHR/17.01
Interim guidance, 6 October 2021
Direct detection of SARS-CoV-2 viral proteins (antigens) in nasal swabs and other respiratory secretions using lateral flow immunoassays (also known as rapid diagnostic...
This WHO information note provides an updated list of recommended criteria for selecting RDTs for malaria, and highlights the performance of RDTs evaluated by the WHO malaria RDT product testing programme. It also provides an overview of additional considerations ... the procurement of rapid tests.
Clinical guideline, Methods, Evidence and Recommendations
In this guideline the following is covered: information needs of people with chronic hep
titis B and their carers; where children, young people and adults with chronic hepatitis B a-
shoul...
On 13 August 2024, Africa Centres for Disease Control and Prevention (Africa CDC) declared the ongoing Mpox outbreak a Public Health Emergency of Continental Security (PHECS). This was followed the next day by the World Health Organization (WHO), which extended the alert internationally as a public ...
This report, published in conjunction with a summary overview of results of rounds 1–8, is the eighth and final report in a series of laboratory-based evaluations of rapid ... tests (RDTs) for malaria. It provides a comparative measure of their performance in a standardized way to distinguish between well and poorly performing tests.
These results constitute the laboratory evaluation component of the WHO prequalification process for malaria RDTs and inform the current WHO procurement recommendations. In round 8, 35 RDTs from 17 manufacturers were assessed. For the first time the evaluation included an assessment of product performance against a panel of P. falciparum parasites with pfhrp2/3 gene deletions and therefore not expressing HRP2.
Laboratory diagnosis of Buruli ulcer
recommended
A manual for health care providers.
This manual provides expert guidance on the laboratory techniques and procedures used in the diagnosis of Buruli ulcer, a disease caused by Mycobacterium ulceran...
Interium guidance, 25 June 2021Timely and accurate diagnostic testing is an essential tool in preventing and controlling the spread of COVID-19. This document describes recommendations for national ...
The purpose of this TPP is to communicate the minimum and ideal characteristics desired to meet the need for discriminating low levels of risk for transmission, i.e. targeted prevalence thresholds in the surveyed areas. An ... vitro diagnostic test is needed for the detection of analyte(s) specific to Wuchereria bancrofti, Brugia malayi, and Brugia timori to aid in the surveillance of defined geographic areas as to whether infection and/or transmission potential has increased (recrudescence) or decreased (elimination of transmission).
6 July 2021. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included.
The latest operational handbook includes the new classes recommended by WHO. It aims at facilitating the implementation of the WHO recommendations by the Member States, technical partners, and ot...
This policy guideIine is intended for use by healthcare professionals invoIved in the management of Covid-19 in South Africa. The document provides guidance on ... tests available, on antigen test performance and accessibility. 1t focuses on key issues such as when to
Perform antigen tests′ how to use and interpret results. Capturing and reporting testing information is also covered.
Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World Health Organization (WHO) announces that current WHO recommendations for the use of interferon-...
This guidance is intended to be used by programme managers following the decision to introduce human papillomavirus (HPV) virological testing as a screening assay in their national cervical cancer prevention and control programme. The guidance inclu...
Qualitative assay for use on the cobas®6800/8800 Systems. For in vitro diagnostic use
